Genmab — Maj 2019
-
I 2017 var det 230 dage. http://www.pharmexec.com/how-fast-are-fda-fast-lanes
-
ASCO – AMG 510 is obviously the most interesting program but it will be hard to meet expectations. Other than that couldn’t find anything earth shattering in the abstracts. There should be an update on BCMA bispecifics, I found JNJ’s EGFR/MET bsAb intriguing but efficacy wasn’t stellar. Looking forward to seeing SGEN’s Nectin4 data in bladder cancer as well.
-
-
hvis MAIA fejler er dette ikke nok, det er stensikkert
-
og hvorfor skulle det fejle, vi kender jo data
-
vi er helt enige, minder mig om den CMD dag, hvor David legede en kæmpe elefant i en porcelænsbutik
-
helt enig, den dag står helt frisk, vi tabte begge en formue på no time
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind